Blue Biofuels Q3: Cash Down to $6,473, Going-Concern Warning Reiterated
BIOF sits 74% above its 52-week low of $0.066.
Summary
Blue Biofuels posted a Q3 net loss of $1.39 million with only $6,473 of cash left and repeated its going-concern warning, leaving the company dependent on insider loans and small private placements to fund operations.
Key Events · Earnings and Guidance · BIOF
-
Cash Nearly Exhausted
Cash and equivalents fell to $6,473 at September 30, 2026 from $65,200 at December 31, 2025, against a working capital deficit of $3,659,437.
-
Going-Concern Warning Repeated
Accumulated deficit reached $62,930,226, and management states substantial doubt about the company's ability to continue as a going concern absent new financing.
-
Q3 Loss Widened
Net loss for the quarter was $1,385,268 versus $422,547 a year earlier; nine-month loss was $2,799,864 versus $1,587,132, with $805,834 of Q3 stock-based compensation.
-
Debt Rose on Insider Loans
Total notes payable increased to $2,384,000 from $1,835,630, including $260,000 borrowed from director Chris Kneppers and $274,000 of convertible notes from unrelated parties.
Analysis · BIOF · Industrial Applications And Services
With cash of just $6,473 at September 30 against a $3.66 million working capital deficit and a $62.9 million accumulated deficit, management again flags substantial doubt about the company's ability to continue as a going concern. The quarter's $1.39 million net loss was more than triple the prior-year period, driven largely by non-cash stock compensation of $805,834. Survival now hinges entirely on continued related-party lending and small private placements: the company raised $347,000 of equity and $649,000 of notes in the first nine months, and after quarter-end took another $87,000 from a board member and $186,000 from an unrelated lender convertible at $0.09. The June 24 board action also committed to issuing anti-dilution options to four executives on every future raise through the next $50 million, so each new financing further dilutes outside holders.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BIOF was trading at $0.12 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $37.3M. The 52-week trading range was $0.07 to $0.20. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.